A multicenter, open-label phase II study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of…
Robin Veerman16 March 2021
A phase IIb trial, multicenter, randomized, double-blind, placebo-controlled study of the safety, tolerability and efficacy…
Robin Veerman10 December 2020
A phase II, multicenter, study of the effects of the research drug ALZ-801 on biomarkers…
Robin Veerman9 December 2020
A phase II / III, multicenter, randomized, double-blind controlled trial. The aim is to learn…
Robin Veerman8 December 2020
A phase IIb / III, double-blind, randomized, placebo-controlled study on the safety and effectiveness of…
Robin Veerman7 December 2020
Phase Ib / IIa, multicentre, randomized, double-blind, placebo-controlled study. The study examines the safety, tolerability,…
Robin Veerman6 December 2020
Phase II study, single center, randomized, double blind, placebo controlled. The study will investigate the…
Robin Veerman5 December 2020
Phase II / III, randomized, double-blind, placebo-controlled study. With this study, the researchers want to…
Robin Veerman4 December 2020
Phase II trial, multicenter, randomized, double-blind, placebo-controlled. The research drug T-817MA is a new drug…
Robin Veerman3 December 2020
